共 106 条
[1]
Lysaght MJ(2002)Maintenance dialysis population dynamics: current trends and long-term implications J Am Soc Nephrol. 13 S37-40
[2]
Iseki K(2003)Proteinuria and the risk of developing end-stage renal disease Kidney Int. 63 1468-1474
[3]
Ikemiya Y(2005)Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study J Am Soc Nephrol. 16 1775-1780
[4]
Iseki C(1995)Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study Ann Intern Med. 123 754-762
[5]
Zhang Z(2005)The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension Arch Intern Med. 165 947-953
[6]
Shahinfar S(2006)Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening J Am Soc Nephrol. 17 2582-2590
[7]
Keane WF(2001)Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 421-426
[8]
Peterson JC(2003)Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study Ann Intern Med. 139 901-906
[9]
Adler S(2005)Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study Circulation. 112 969-975
[10]
Burkart JM(2005)Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study Hypertension 45 198-202